Form 4 for ASTH Astrana Health, Inc.
Accepted 2026-04-15 16:15:37 ET · period of report 2026-04-14 · accession 0001104659-26-043808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 16:15 | 2026-04-14 | ASTH | Basho Chandan | COO, CFO | F - Tax | $29.07 | -3,870 | 167.8K | -2% | -$112.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-14 | F | D | 3,870 | $29.07 | 167,765 | D | — | — | (F1) Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026. (F2) Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. |